Table 1.
Characteristics of matched patients
| Salvage (n = 96) No. (Range or %) | Adjuvant (n = 96) No. (Range or %) | |
|---|---|---|
| Age (y [median]) | 63.0 (47-75) | 62.0 (42-76) |
| Preop PSA (ng/dL) | ||
| Median | 9.0 (1.7-39) | 8.3 (1.1-65.9) |
| ≤10 | 55 (57%) | 56 (58%) |
| >10 | 41 (43%) | 40 (42%) |
| Gleason score | ||
| 2-6 | 22 (23%) | 22 (23%) |
| 7 | 57 (59%) | 57 (59%) |
| 8-10 | 17 (18%) | 17 (18%) |
| Seminal vesicle invasion | 23 (24%) | 23 (24%) |
| Surgical margin status | ||
| Positive | 80 (83%) | 80 (83%) |
| Negative | 16 (17%) | 16 (17%) |
| Length of follow-up (mon [median]) | ||
| From date of surgery | 94 (26-190) | 97 (30-207) |
| From date of RT | 58 (1-126) | 90 (24-200) |
| Radiation dose (Gy [median]) | 64.8 (59-70) | 60 (50-70)* |
Preop PSA = preoperative prostate-specific antigen; RT = radiation therapy.
*
P < .0001. No other statistical differences were found in the tumor or treatment parameters.